Entheon Biomedical Corp. has terminated its planned business combination with Nutravisor Inc., canceling the reverse takeover and related corporate changes. As part of the termination, Nutravisor paid Entheon a CAD$175,000 cash settlement and agreed to issue shares valued at the same amount. The termination means Entheon will not proceed with the previously planned share consolidation or name change. Trading of Entheon's shares remains halted, with further updates expected.
Flowers Foods shares fell 13.3% following a disappointing Q1 earnings and revenue report. Despite the setbacks, management is focused on a turnaround strategy involving cost-cutting, operational simplification, and discontinuing underperforming produ...
The US Department of Justice has seized over 1 bitcoin linked to Wei Gong, a Chinese national arrested for importing synthetic drugs into Georgia. The case involved tracing Binance account records, blockchain analysis, and cooperation with Chinese au...
TruBridge, Inc. disclosed errors in its previously issued financial statements for 2023 and 2024, leading to a late filing of its 2025 annual report. The errors involve revenue recognition, contract costs, stock-based compensation, and capitalized so...
BNB Chain has introduced the Agent Survival Pack, a bundle of six AI infrastructure projects that allows autonomous AI agents to manage and pay their operational costs directly on the BNB Smart Chain using BNB or BEP-20 tokens. This innovation uses t...
JOYY Inc. posted a 12.4% year-over-year revenue increase to $555.7 million in Q1 2026, driven by growth in social entertainment, BIGO Ads, and SHOPLINE e-commerce segments. BIGO Ads revenue surged 55.6%, while SHOPLINE grew 16.1%. The company also an...
